Speaker illustration

Mr Ulises Lopez

Bellvitge University Hospital, Hospitalet De Llobregat (Spain)

Member of:

European Society of Cardiology
Heart Failure Association

Differences in patients with early and late toxic cardiomyopathy post-chemotherapy: characteristics and prognosis

Event: Heart Failure 2019

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb